Motavizumab

From Ganfyd

Jump to: navigation, search

Development of motavizumab, a monoclonal antibody that bound to a conserved neutralizing epitope on the RSV F protein and was thought to prevent essential steps of the infection process was discontinued in 2010. It was similar to palivizumab.

Personal tools